4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-203344
EVP, Chief Development Officer acquired 23,464 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Forbes William P · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Exercise or conversion : show line 1 in the form | +11,694 | 197,341 | D |
| 2026-04-30 | Exercise or conversion : show line 2 in the form | +11,770 | 209,111 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −11,694 | 128,638 | D |
| 2026-04-30 | Exercise or conversion : show line 4 in the form Restricted Stock Units | −11,770 | 176,545 | D |
Loading xslF345X06/ownership.xml…